Oram M, Fisher L M
Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, United Kingdom.
Antimicrob Agents Chemother. 1991 Feb;35(2):387-9. doi: 10.1128/AAC.35.2.387.
Seven nalidixic acid-resistant clinical isolates of Escherichia coli were shown to carry resistance mutations in their gyrase A proteins. Six had serine-83 to leucine or tryptophan changes; the seventh had an aspartate-87 to valine substitution. The frequent occurrence of a mutation at serine-83 implies a key role for this residue in quinolone action.
七株耐萘啶酸的大肠杆菌临床分离株在其促旋酶A蛋白中存在耐药性突变。其中六株有丝氨酸83突变为亮氨酸或色氨酸;第七株有天冬氨酸87被缬氨酸取代。丝氨酸83处频繁发生突变意味着该残基在喹诺酮作用中起关键作用。